Table 2

Sample characteristics of Diabetes MILES – The Netherlands (2011)
All Type 1 diabetes Type 2 diabetes
(n=3,960) (n=1,573) (n=2,108)
Demographics
 Women 54% (2,133/3,925) 61% (958/1,572) 48% (1,020/2,108) ‡
 Age in years 55 ± 14 47 ± 15 62 ± 10 ‡
 Ethnic minority 3% (104/3,884) 2% (34/1,573) 3% (58/2,108)
 Educational level
  Low 27% (1,040/3,870) 19% (293/1,571) 33% (684/2,101)
  Middle 34% (1,313/3,870) 35% (546/1,571) 34% (704/2,101)
  High 39% (1,517/3,870) 47% (732/1,571) 34% (713/2,101) ‡
 Having a partner 80% (3,107/3,889) 80% (1,260/1,573) 80% (1,682/2,108)
 Paid employment 48% (1,838/3,873) 63% (992/1,571) 36% (763/2,104) ‡
Clinical characteristics
 Duration of diabetes in years 16 ± 13 23 ± 15 11 ± 8 ‡
 Diabetes treatment
  Insulin pump 24% (910/3,786) 48% (761/1,572) 6% (125/2,102) ‡
  Insulin injections 50% (1,891/3,786) 53% (830/1,572) 47% (995/2,102) †
  Glucagon-like peptide-1 (GLP-1) agonist injections 2% (62/3,786) 0.1% (2/1,572) 3% (59/2,102) ‡
  Blood glucose lowering tablets 44% (1,627/3,664) 7% (111/1,566) 74% (1,474/1,987) ‡
  Lifestyle only 3% (99/3,726) 0% (0/1,572) 5% (95/2,042) ‡
 Most recent HbA1c (mmol/mol) 56 ± 12 58 ± 12 54 ± 12 ‡
 Body Mass Index (kg/m2) 28 ± 6 25 ± 5 30 ± 6 ‡
 Macro-vascular disease and/or micro-vascular complications *
  None 69% (2,544/3,691) 70% (1,077/1,539) 68% (1,383/2,041)
  One 20% (729/3,691) 18% (276/1,539) 21% (436/2,041)
  Two or more 11% (418/3,691) 12% (186/1,539) 11% (222/2,041) †

Values are mean ± standard deviation, unless otherwise specified.

* Self-reported myocardial infarction, stroke, peripheral arterial disease, nephropathy, retinopathy, neuropathy and/or foot condition.

† Difference between self-reported type 1 and type 2 diabetes p < 0.05.

‡ Difference between self-reported type 1 and type 2 diabetes p < 0.001.

Nefs et al.

Nefs et al. BMC Public Health 2012 12:925   doi:10.1186/1471-2458-12-925

Open Data